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Abstract
Rhabdomyosarcoma is the most common soft tissue malignancy of childhood, but may occur
extremely rarely in the neonatal period. There are only a few reports of rhabdomyosarcoma in
neonates. Although, it may arise anywhere in the body, the head and neck, and genitourinary regions
are the most frequent sites. Truncal and chest wall rhabdomyosarcoma is relatively rare occurrence.
We report a neonate with embryonal rhabdomyosarcoma arising from the posterior chest wall
muscles at birth. Computer Tomography scan raised the possibility of rhabdomyosarcoma or
neurofibroma, fine-needle aspiration cytology was inconclusive. Total excision was done and
chemotherapy given. At 6 months child is without recurrence.
Introduction
Rhabdomyosarcoma(RMS) isthe most common soft tissue
malignancy ofchildhood,but may occurextremelyrarelyin
the neonatal period [1,2]. There are only a few reports of
RMS in neonates [3,4]. Although, it may arise anywhere in
the body, but it has a predilection for the head and neck
area, genitourinary tract and the extremities [2]. Chest wall
is a rare site for RMS [2,5]. We report a neonate with
embryonal RMS arising from the posterior chest wall
muscles at birth. CT scan raised the possibility of RMS or
neurofibroma, FNAC was inconclusive. Total excision was
done and chemotherapy given. At 6 months child is
without recurrence. Case is reported because of extreme
rarityofRMStooccurinneonatesandthattooinchestwall.
Case presentation
An Indian, Hindu male baby was referred from the
nursery, just three hours after birth with a congenital
swelling on right side of his upper back. Baby was the first
born child to a 29-year-old healthy mother at 38 weeks of
gestation by normal vaginal delivery. On examination,
there was a firm, oval, non-tender, slightly movable mass
of size 6 × 5 cm situated on the posterior chest wall in right
para-vertebral and right intra-scapular region (Figure 1).
Lymph nodes in axillary or supra-clavicular region were
not clinically palpable. It was not associated with any
congenital anomaly. Chest X-ray showed an oval soft
tissue shadow at the involved site (Figure 2). On
ultrasound a homogenous soft tissue mass without
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and it demonstrated a minimally enhancing low-attenuat-
ing soft tissue mass of size 6.3 × 5.6 × 3.0 cm, localized in
posterior chest wall in right para-vertebral and right intra-
scapular region (Figure 3A & 3B). There was no intra-
spinal or intra-thoracic extension. Possibility of RMS or
neurofibroma was raised on CT. Fine needle aspiration
cytology (FNAC) of mass remained inconclusive. On
5
th post-natal-day day, total excision of the mass was done
(Figure 4A). Intraoperatively mass could be easily separ-
able from the surroundings. Histopathological examina-
tion showed features of embryonal RMS (Figure 4B).
Specimen was sent for immuno-histochemical studies
which came out to be positive for vimentin, myogenin and
muscle specific actin. Patient was referred for chemother-
apy which was taken. At 6 months of follow-up he is doing
well without recurrence, although 6 months period is too
early to comment on recurrence.
Discussion
Rhabdomyosarcoma (RMS), a malignant tumor of imma-
ture mesenchymal cell origin, is the most common soft
tissue sarcoma in the pediatric age group, accounting for
approximately 3-5% of all childhood malignancies [1].
Figure 1. Pre-operative photograph of the back of a neonate
showing a mass of size 6 × 5 cm situated on the posterior
chest wall in right para-vertibral and right scapular region.
Figure 2. Babygram of the patient showing a soft tissue
shadow on right scapular region.
Figure 3. (A) & (B) (Transverse and Sagital views): CT-scan
chest and upper abdomen of a newborn who presented with a
hard mass on his back of chest, showing a minimally enhancing
low-attenuating soft tissue mass, localized in posterior chest
wall in right para-vertibral and right intra-scapular region.
Figure 4. (A) Post-operative specimen after total excision of
the mass. (B) Histopathological examination showing features
of embryonal RMS.
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thirds of all patients are diagnosed before 10 years of age,
the tumor being rare in adults [6]. However, occurrence of
RMS in the neonatal period is extremely rare: approxi-
mately, only 1-2% of all cases are congenital [6,7]. There
are only a few reports about neonatal RMS in the literature
[3,4]. Of 3,217 patients registered in the Intergroup
Rhabdomyosarcoma Study (IRS) I-IV, only 14 were in
the neonatal period at the time of diagnosis [8]. Report
from the Italian Cooperative Group by Ferrari et al. [7]
among 50 infants with RMS over 20 years, 15 were
considered as having congenital RMS. Rodriguez et al. [9],
reported only four patients with neonatal RMS treated
during 37 years (1962-1999). Thus knowledge about RMS
in this age group is scars [3,10].
RMS is traditionally subdivided into embryonal, alveolar
and pleomorphic. Pleomorphic RMS, in contrast to
embryonal and alveolar RMS, almost exclusively occurs
in adults (median age sixth decade). Alveolar RMS
represents about 20% of all RMS [11]. Embryonal RMS
is the most common type (60-70% of all RMS) [8,10], and
is the most predominant in neonates, infants and young
children [5,12].
Primary soft-tissue sarcomas of the chest wall are
uncommon. RMS usually occurs in the head and neck
region (particularly the orbit, nasopharynx, middle ear
and oral cavity), bile ducts, retroperitoneum, urogenital
tract and extremities [2]. In the first three IRS trials, 35% to
40% of all tumors arose from the head and neck region,
about 25% from the genitourinary tract, approximately
20% from extremities, 10% from truncal primary tumors
and the remaining 10% from other miscellaneous sites
[10]. Thus, chest wall RMS is a relatively rare finding with a
reported incidence of 3.7% in the IRS II and IRS III studies
[5]. Most of the reports of chest wall involvement are
either case reports or small series [5,13] these too in
childhood age group.
It has been noted in congenital RMS that the disease may
be metastatic at the time of birth, with metastases
described in a number of organs and in the placenta
too [14].
MRI is the primary imaging modality in RMS with its
superior ability to depict soft-tissue changes. CT of the
chest is mandatory in order to assess pulmonary metas-
tases from RMS [11]. In our case CT scan of chest and
upper abdomen was done, which suggested the possibility
of RMS or neurofibroma. Even FNAC did not yield any
conclusive result.
Age less than one year has emerged as an independent
poor prognostic factor for RMS [8,15]. Regarding the site,
RMS occurring at the trunk, para-meningeal areas and the
extremities, has been mentioned to be associated with
short survival rates. These sites are referred to as non-
favourable sites. On the other hand, patients with primary
lesions at non-parameningeal regions of the head and
neck, and the genitourinary system, had long survival
rates [16]. The chest wall is an unfavorable site [17].
Histological features of necrosis and small round cell
pattern is liked with a poor prognosis, regardless of final
histological diagnosis [8]. Therefore, age of the patient,
location of the tumor, histopathologic features and
metastatic status all are important prognostic factors for
RMS [18].
Treatment of neonatal RMS requires a multidisciplinary
approach, where surgery and chemotherapy both have
their own specific role. Complete resection of chest wall
rhabdomyosarcoma is recommended [19]. Embryonal
RMS generally respond very well to chemotherapy [17].
However, a prolonged follow-up is necessary to evaluate
the outcome of treatment. Good response to chemother-
apy allows surgery to be done less aggressively if needed
[20]. The use of radiotherapy is restricted by very high risk
of side effects [7] and it should be avoided in the
newborns [21]. Thus the role of paediatric oncologists,
radiologists, paediatric surgeons and pathologists all is
important [12].
In conclusion, we report a rare case of posterior chest wall
congenital embryonal rhabdomyosarcoma in a newborn,
which responded well to surgery and chemotherapy. In a
newborn presenting with a hard mass arising from chest
wall, RMS should be considered as one of the differential
diagnoses.
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